Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Jacksonville Wealth Management LLC

Jacksonville Wealth Management LLC trimmed its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 0.7% in the first quarter, HoldingsChannel.com reports. The firm owned 4,851 shares of the biotechnology company’s stock after selling 35 shares during the quarter. Axon Enterprise comprises approximately 2.5% of Jacksonville Wealth Management LLC’s investment portfolio, making the stock its 11th biggest holding. Jacksonville Wealth Management LLC’s holdings in Axon Enterprise were worth $2,551,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in AXON. Brighton Jones LLC acquired a new stake in Axon Enterprise in the fourth quarter worth approximately $480,000. Kingsview Wealth Management LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at $212,000. Empowered Funds LLC increased its holdings in shares of Axon Enterprise by 89.2% in the fourth quarter. Empowered Funds LLC now owns 1,871 shares of the biotechnology company’s stock valued at $1,112,000 after buying an additional 882 shares in the last quarter. Savant Capital LLC increased its holdings in shares of Axon Enterprise by 5.7% in the fourth quarter. Savant Capital LLC now owns 1,080 shares of the biotechnology company’s stock valued at $642,000 after buying an additional 58 shares in the last quarter. Finally, Summit Trail Advisors LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at $281,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

AXON has been the topic of several research reports. Barclays upped their price target on Axon Enterprise from $726.00 to $735.00 and gave the company an “overweight” rating in a report on Friday, May 9th. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Bank of America upped their price target on Axon Enterprise from $750.00 to $895.00 and gave the company a “buy” rating in a report on Wednesday, June 4th. Craig Hallum cut Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Finally, Needham & Company LLC upped their price target on Axon Enterprise from $600.00 to $750.00 and gave the company a “buy” rating in a report on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $699.55.

Insider Transactions at Axon Enterprise

In other news, Director Michael Garnreiter sold 5,913 shares of the company’s stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $760.00, for a total value of $4,493,880.00. Following the transaction, the director now directly owns 17,740 shares of the company’s stock, valued at approximately $13,482,400. This represents a 25.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the transaction, the chief executive officer now directly owns 3,063,982 shares in the company, valued at $1,657,583,622.18. This trade represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 43,969 shares of company stock valued at $29,909,594. 4.40% of the stock is owned by insiders.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $775.20 on Friday. The company’s fifty day moving average is $663.94 and its two-hundred day moving average is $620.60. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12-month low of $279.02 and a 12-month high of $806.64. The company has a market cap of $60.35 billion, a P/E ratio of 200.31, a price-to-earnings-growth ratio of 5.17 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The business had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. During the same period in the prior year, the business posted $1.15 earnings per share. Axon Enterprise’s revenue for the quarter was up 31.3% compared to the same quarter last year. Equities analysts expect that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.